CORE BIOMEDICINE: CO OBTAINED EXCLUSIVE, GLOBAL RIGHTS TO CERTAIN PRECLINICAL ONCOLOGY PROGRAMS THAT TARGET KEY MOLECULAR DRIVERS OF VARIOUS CANCERS

Reuters · 2d ago

Please log in to view news